Marielle Bassel

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The complexity of finding fit-for-purpose real-world data for oncology patients with rare NTRK gene fusions and a novel solution.

The complexity of finding fit-for-purpose real-world data for oncology patients with rare NTRK gene fusions and a novel solution.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with noncomplicated or complex Crohn's disease: results from the EVOLVE Expansion study.

Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with noncomplicated or complex Crohn's disease: results from the EVOLVE Expansion study.

Journal: European journal of gastroenterology & hepatology

Published: August 18, 2025

Real-World Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn's Disease: Results From the EVOLVE Expansion Chart Review Study.

Real-World Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn's Disease: Results From the EVOLVE Expansion Chart Review Study.

Journal: Journal of clinical gastroenterology

Published: May 14, 2025

Real-world Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-naive Patients With Crohn's Disease: Results From the EVOLVE Study.

Real-world Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-naive Patients With Crohn's Disease: Results From the EVOLVE Study.

Journal: Journal of clinical gastroenterology

Published: January 30, 2024

Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.

Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.

Journal: Antiviral therapy

Published: September 01, 2023

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.

Journal: Journal of Crohn's & colitis

Published: March 31, 2021

Retrospective Chart Review Studies: Strategies To Ensure Robust Data Quality.

Retrospective Chart Review Studies: Strategies To Ensure Robust Data Quality.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 01, 2014

Physical and occupational therapy referral and use among systemic sclerosis patients with impaired hand function: results from a Canadian national survey.

Physical and occupational therapy referral and use among systemic sclerosis patients with impaired hand function: results from a Canadian national survey.

Journal: Clinical and experimental rheumatology

Published: October 11, 2011

Showing 1-8 of 8

Last Updated: 09/26/2026